TAP1 and cancer: Furthermore, a knock-down of TAP-1 gene or epigenetic changes and TAP-1 protein downregulation, as well as the loss of tapasin, an essential component of the peptide-loading complex (PLC) in human cancer cells, elicits tumour immune escape by inhibiting CTL surveillance against the tumour.